Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis.
We measured the density and affinity of muscarinic cholinergic receptors (MR) in 29 chronic progressive and ten stable multiple sclerosis (MS) patients and 27 control subjects using [3H]N-methyl-scopolamine. The density of MR on CD4+ lymphocytes was significantly higher in chronic progressive MS (CPMS) than in controls (7.9 +/- 0.7 vs. 4.5 +/- 0.4 fmol/10(6) cells, p less than 0.001). Stable patients did not differ significantly from control subjects. Receptors of the M1 subtype were measured on CD4+ lymphocytes of nine patients and seven controls with the selective antagonist [3H]methylpirenzepine: M1/total receptor ratio was 64.1% in CPMS and 81.2% in controls, suggesting a selective increase of M2-type MR in CPMS. The findings may relate to parasympathetic denervation hypersensitivity of lymphocytes or to lymphocyte activation which is known to be associated with increased MR number.
Department of Neurology, University of Chicago, IL 60637.
B
B
Anlar
J W
JW
Karaszewski
A T
AT
Reder
B G
BG
Arnason
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000737:chemistry*; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000737:chemistry; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000737:chemistry; D009103:Multiple Sclerosis / Q000378:metabolism*; D019832:N-Methylscopolamine; D011976:Receptors, Muscarinic / Q000032:analysis*; D012602:Scopolamine Derivatives / Q000378:metabolism; D006377:T-Lymphocytes, Helper-Inducer / Q000737:chemistry*
D011976:Receptors, Muscarinic; D012602:Scopolamine Derivatives; D019832:N-Methylscopolamine